No abstract

Aspects of the female body may be attractive because they signal evolutionary fitness. Greater body fatness might reflect greater potential to survive famines, but individuals carrying larger fat stores may have poor health and lower fertility in non-famine conditions. A mathematical statistical model using epidemiological data linking fatness to fitness traits, predicted a peaked relationship between fatness and attractiveness (maximum at body mass index (BMI) = 22.8 to 24.8 depending on ethnicity and assumptions). Participants from three Caucasian populations (Austria, Lithuania and the UK), three Asian populations (China, Iran and Mauritius) and four African populations (Kenya, Morocco, Nigeria and Senegal) rated attractiveness of a series of female images varying in fatness (BMI) and waist to hip ratio (WHR). There was an inverse linear relationship between physical attractiveness and body fatness or BMI in all populations. Lower body fat was more attractive, down to at least BMI = 19. There was no peak in the relationship over the range we studied in any population. WHR was a significant independent but less important factor, which was more important (greater r2) in African populations. Predictions based on the fitness model were not supported. Raters appeared to use body fat percentage (BF%) and BMI as markers of age. The covariance of BF% and BMI with age indicates that the role of body fatness alone, as a marker of attractiveness, has been overestimated.

Background: Obesity is currently a global epidemic. Conventional treatments have not been very satisfactory to patients, warranting a search for alternative therapeutic options that are natural, safe and affordable. This study therefore investigated the anti-obesity potentials of aqueous and methanol extracts of Vernonia amygdalina Del (AEVA and MEVA respectively) in a rat model in which obesity was induced using a high-fat diet. Materials and Methods: Forty two Wistar rats were randomised into 7 groups of 6 rats each. One group served as the Normal Control group and obesity was induced in the other 6 groups. One of the 6 groups each served as Positive Control and Negative Control while the 4 test groups were designated AEVA100, AEVA500, MEVA50 and MEVA200, respectively. The study lasted for 12 weeks after which standard protocols were followed for all analyses and determinations. Results: The results show that both AEVA and MEVA at the tested concentrations resulted in significant (P < 0.05) weight loss (without affecting internal organs negatively), and significant (P < 0.05) improvement in some metabolic markers of obesity in the test rats compared to the negative control rats. MEVA 200 had the greatest anti-obesity effect while MEVA 50 was the least effective. All the test extracts compared well with Orlistat used as the positive control drug on all counts. Conclusion: The observed weight-loss benefits of AEVA and MEVA are attributable to the rich milieu of phytochemicals found in Vernonia amygdalina Del. Further studies to unlock the mechanisms through which the observed weight loss is mediated are warranted.

Diabetes mellitus is a global health problem that is causing problems for humans around the world and becoming increasingly prevalent at an alarming rate (Aloulou et al., 2012), including amongst the rural Nigerian population. The inability of modern treatments to control all the pathophysiological aspects of diabetes, as well as the enormous cost it imposes on the economy of the developing nations of the world, ABSTRACTBackground. Although African breadfruit (Treculia africana) is said to be useful in the dietary management of diabetes, the effect of cooking on its glycemic index has not been reported. Hence this study has investigated the effect of a dietary intake of boiled breadfruit on the serum glucose, glucose tolerance, body weights and relative organ weights of streptozotocin (STZ) induced diabetic rats. Materials and methods. Twenty albino rats were used and were divided into four groups of five rats. Groups 1 (normal control) and 2 (diabetic control) received standard rat pellets while groups 3 (diabetic-test group) and 4 (non-diabetic) rats received breadfruit. Results. The blood glucose of the normoglycemic rats fed standard rat feeds peaked at 30 min (149.75 ±11.12 mg/dl) following oral glucose loading (3 g/kg) but reduced to 85.25 ±21.05 mg/dl after another 90 min, while the blood glucose of the normoglycemic rats fed breadfruit peaked at 30 min (146.25 ±15.22 mg/dl) following oral glucose loading, but elevated (130.75 ±36.69 mg/dl) after another 90 min. There was significant elevation (P < 0.05) of the serum glucose, relative liver weight (RLW) and relative kidney weight (RKW) but a significant decrease in the body weights of the diabetic control compared with the normal control; no significant difference (P > 0.05) in the serum glucose, body weights, RLW and RKW of the test group compared with the diabetic control, and no significant differences (P > 0.05) in the serum glucose, body weights, RLW and RKW of the normal rats fed the breadfruit diet compared to the normal control. Conclusion. The study showed that the traditional method of cooking African breadfruit negatively affects its hypoglycemic property.

Background: Obesity is currently a global epidemic. Conventional treatments have not been very satisfactory to patients, warranting a search for alternative therapeutic options that are natural, safe and affordable. This study therefore investigated the anti-obesity potentials of aqueous and methanol extracts of Vernonia amygdalina Del (AEVA and MEVA respectively) in a rat model in which obesity was induced using a high-fat diet. Materials and Methods: Forty two Wistar rats were randomised into 7 groups of 6 rats each. One group served as the Normal Control group and obesity was induced in the other 6 groups. One of the 6 groups each served as Positive Control and Negative Control while the 4 test groups were designated AEVA100, AEVA500, MEVA50 and MEVA200, respectively. The study lasted for 12 weeks after which standard protocols were followed for all analyses and determinations. Results: The results show that both AEVA and MEVA at the tested concentrations resulted in significant (P < 0.05) weight loss (without affecting internal organs negatively), and significant (P < 0.05) improvement in some metabolic markers of obesity in the test rats compared to the negative control rats. MEVA 200 had the greatest anti-obesity effect while MEVA 50 was the least effective. All the test extracts compared well with Orlistat used as the positive control drug on all counts. Conclusion: The observed weight-loss benefits of AEVA and MEVA are attributable to the rich milieu of phytochemicals found in Vernonia amygdalina Del. Further studies to unlock the mechanisms through which the observed weight loss is mediated are warranted.